junio 13, 2024 Statement Destiny Lopez, Acting Co-CEO of the Guttmacher Institute, on the US Supreme Court's Decision in FDA v. AHM
junio 12, 2024 Statement Testimony of Isaac Maddow-Zimet, Guttmacher Data Scientist, before the U.S. Senate Subcommittee on Federal Courts, Oversight, Agency Action, and Federal Rights
junio 4, 2024 Statement Testimony of Destiny Lopez Guttmacher Acting Co-CEO before the U.S. Senate Committee on Health, Education, Labor, and Pensions
mayo 31, 2024 Policy Analysis Clear and Growing Evidence That Dobbs Is Harming Reproductive Health and Freedom
mayo 6, 2024 Policy Analysis First Quarter 2024 State Policy Trends: An Evolving Focus of Attacks on Abortion, Youth Access, IVF and More
mayo 3, 2024 Statement Guttmacher Statement at the 57th Session of the UN Commission on Population and Development
abril 22, 2024 Statement Destiny Lopez, acting co-CEO of the Guttmacher Institute, Calls on the US Supreme Court to Protect Abortion in Emergency Situations
marzo 19, 2024 Policy Analysis Medication Abortion Accounted for 63% of All US Abortions in 2023—An Increase from 53% in 2020
marzo 19, 2024 Policy Analysis Despite Bans, Number of Abortions in the United States Increased in 2023